GENFLOW BIOSCIENCES PLC (WQ5) — Financial Flexibility Index
GENFLOW BIOSCIENCES PLC (WQ5) has a Financial Flexibility Index of -1.37x as of December 2024. Free cash flow of €-1.08 Million (operating CF €-1.08 Million minus capex €0.00) represents -1% of total liabilities (€788.92K). Check WQ5 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GENFLOW BIOSCIENCES PLC Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for GENFLOW BIOSCIENCES PLC across 4 annual periods. For the full cash flow conversion analysis, see GENFLOW BIOSCIENCES PLC cash conversion from operations.
Annual Financial Flexibility Index for GENFLOW BIOSCIENCES PLC (2021–2024)
Year-by-year free cash flow to debt coverage for GENFLOW BIOSCIENCES PLC. Explore GENFLOW BIOSCIENCES PLC cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | €-1.08 Million | €-1.08 Million | €788.92K | ▲ +52.7% |
| 2023 | -2.90x | €-1.66 Million | €-1.66 Million | €571.96K | ▲ +46.7% |
| 2022 | -5.44x | €-1.37 Million | €-1.37 Million | €250.99K | ▼ -61.2% |
| 2021 | -3.38x | €-747.38K | €-747.38K | €221.43K | — |